Clinical Trials Browser

Unknown × Carcinoma, Non-Small-Cell Lung × Surgical Procedures, Operative × Clear all

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT04040361 2022-04-06

Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer (EAST ENERGY)

Phase 2 Unknown

24 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04540757 2022-02-03

PIONEER

Unknown

66 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04943029 2021-09-02

NEOSUN

Phase 2 Unknown

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04470076 2020-07-14

Neoafa

Phase 2 Unknown

30 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03710616 2019-08-01

A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals

Unknown

700 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03840408 2019-02-20

Mitochondria-targeted System Therapy Combined With Radiofrequency Ablation for Early-stage Non-small Cell Lung Cancer

Phase NA Unknown

1,753 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03427541 2018-02-09

A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases

Unknown

1,000 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01574729 2012-06-28

rAd-p53

Phase 2 Unknown

120 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00273494 2008-05-22

Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2

Phase 3 Unknown

406 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

PITHAC

Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer (EAST ENERGY)

PIONEER

NEOSUN

Neoafa

A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals

Mitochondria-targeted System Therapy Combined With Radiofrequency Ablation for Early-stage Non-small Cell Lung Cancer

A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases

rAd-p53

Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2